Aller au contenu principal
2025 conference-abstract

197 Integrating Histologic and Molecular Features in Meningiomas

0Citations signalées, ce qui n’est pas une note de qualité
0Institutions déclarées
0Pays d’affiliation déclarés

Le résumé fourni par la source

INTRODUCTION: Histologic findings are the primary determinant of meningioma prognosis and post-operative management. However, the relationship of specific pathologic features to molecular alterations has not yet been comprehensively investigated. METHODS: Detailed histological information was collected for 809 resected meningiomas, including cases with DNA methylation (n=380), copy number array (n=252), next-generation sequencing (n=52), RNA risk score (n=394), and/or TERT promoter profiling (n=238). Analyses were conducted on prognostic pathologic features, including WHO Grade, Ki-67, mitotic index (MI), brain invasion, and atypical histologic findings (necrosis, hypercellularity, prominent nucleoli, sheeting, and small cells). Correlation with molecular variables was performed using Fisher’s Exact Tests, including DNA methylation subgroup, RNA risk score, CNV profiles, and TERT promoter mutations. All statistics were corrected for multiple hypothesis testing. RESULTS: Nearly 65% of meningiomas exhibited at least one form of histologic atypia, most commonly increased cellularity or necrosis. Recurrent lesions were associated with sheeting and necrosis, elevated Ki-67/MI, and higher WHO grade. Aggressive histologic features, including increased cellularity, elevated Ki-67/mitotic index, and WHO grade, correlated with DNA methylation and RNA risk groups. Several chromosomal arm events were related to pathologic features (prominent nucleoli, Ki-67, MI, and grade), including chromosomes 1, 4, 10, 14, and 18. CONCLUSIONS: Our analysis highlights the continued value in screening for histologic markers of aggressive behavior in meningiomas, as they correlate with the presence of high-risk molecular features and may serve as proxy markers when advanced molecular testing is not available.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
197 Integrating Histologic and Molecular Features in Meningiomas
Date Crossref
01/04/2025
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les sujets associés

Glioma Diagnosis and TreatmentMeningioma and schwannoma management

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.